Correspondence 0001104659-24-073033 from TriSalus Life Sciences, Inc. (TLSI)
TriSalus Life Sciences, Inc.
Date: June 20, 2024 · CIK: 0001826667 · Accession: 0001104659-24-073033
AI Filing Summary & Sentiment
File numbers found in text: 333-280197
Show Raw Text
CORRESP
1
filename1.htm
TriSalus
Life Sciences, Inc.
6272 W. 91st
Ave.
Westminster, Colorado 80031
June 20, 2024
Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications
and Services
100 F. Street N.E.
Washington, D.C. 20549-3010
Attention: Conlon Danberg
Re:
TriSalus Life Sciences, Inc.
Registration Statement on Form S-1
File No. 333-280197
Ladies and Gentlemen:
TriSalus Life Sciences, Inc. (the “Registrant”)
hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause
the above-referenced Registration Statement on Form S-1 to become effective on Friday, June 21, 2024, at 4:00 p.m., Eastern
Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff
of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP, counsel to the Registrant, to make such request on its
behalf.
Once the Registration Statement has been declared
effective, please orally confirm that event with Carlos Ramirez of Cooley LLP, counsel to the Registrant, at (858) 550-6157.
[Signature Page Follows]
Very truly yours,
TRISALUS LIFE SCIENCES, INC.
By:
/s/ Mary Szela
Name: Mary Szela
Title: Chief Executive Officer
cc:
Carlos
Ramirez, Cooley LLP
Matthew
T. Browne, Cooley LLP
[Company
Signature Page to Acceleration Request]